Effect of SOM230 (Pasireotide) on corticotropic cells: Action in dogs with Cushing's disease
SOM230 (pasireotide) is a multiligand somatostatin (SRIF) analog able to bind to somatostatin receptor (SSTR) subtypes 1, 2, 3 and 5, and trigger antisecretory and antiproliferative signaling cascades. Canines have become in vivo models to test the pharmacological treatment of corticotropinomas beca...
Guardado en:
Publicado: |
2011
|
---|---|
Materias: | |
Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00283835_v94_n2_p124_Castillo http://hdl.handle.net/20.500.12110/paper_00283835_v94_n2_p124_Castillo |
Aporte de: |